J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e ● C o n t e n t s ● C u r r e n t e v e n t s ● R a n d o m a r t i c l e ● A b o u t W i k i p e d i a ● C o n t a c t u s ● D o n a t e
C o n t r i b u t e
● H e l p ● L e a r n t o e d i t ● C o m m u n i t y p o r t a l ● R e c e n t c h a n g e s ● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t ● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t ● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e ● C o n t r i b u t i o n s ● T a l k
( T o p )
1 H i s t o r y
2 R e f e r e n c e s
3 E x t e r n a l l i n k s
T o g g l e t h e t a b l e o f c o n t e n t s
N x S t a g e
A d d l a n g u a g e s
A d d l i n k s
● A r t i c l e ● T a l k
E n g l i s h
● R e a d ● E d i t ● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d ● E d i t ● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e ● R e l a t e d c h a n g e s ● U p l o a d f i l e ● S p e c i a l p a g e s ● P e r m a n e n t l i n k ● P a g e i n f o r m a t i o n ● C i t e t h i s p a g e ● G e t s h o r t e n e d U R L ● D o w n l o a d Q R c o d e ● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F ● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
History [ edit ]
The company was founded by C. David Finch, Jr., MD[3] [4]
In 2003, the company launched System One in the critical care market. It received Food and Drug Administration clearance for home hemodialysis in June 2005.[5]
In October 2005, the company became a public company via an initial public offering .[6]
On November 2, 2005, the company received the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC).[7]
In December 2014, the company received Food and Drug Administration clearance for System One to be used overnight while patients are sleeping.[8]
In August 2017, the company received Food and Drug Administration clearance for System One for solo home hemodialysis, without a care partner, during waking hours.[9]
In February 2019, the company was acquired by Fresenius Medical Care .[10] [11]
References [ edit ]
^ "https://www.youtube.com/watch?v=ODLYNrbJf5I" . YouTube . October 27, 2023. Retrieved 1 June 2024 .
^ Who, Marquis Who's (2014-01-10). "C. David Finch Jr. MD" . Elite American Physicians . Retrieved 2019-10-24 .
^ "Company Overview of NxStage Kidney Care, Inc" . Bloomberg L.P. 15 July 2023.
^ "NxStage Medical Receives FDA Clearance for Home Hemodialysis System" (Press release). Business Wire . June 29, 2005.
^ "NxStage Medical rolls out lower-priced IPO" . American City Business Journals
^ "MassMEDIC Honors NxStage Medical with Innovation Award for Portable Home Hemodialysis System" (Press release). Business Wire . November 2, 2005.
^ Seiffert, Don (December 29, 2014). "NxStage nabs first-ever FDA approval for overnight home hemodialysis" . American City Business Journals
^ "NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™" (Press release). PR Newswire . August 28, 2017.
^ BANNOW, TARA (February 26, 2019). "Fresenius Medical Care closes $2 billion NxStage acquisition" . Modern Healthcare
^ "Fresenius Medical Care completes acquisition of NxStage Medical" (Press release). PR Newswire . February 26, 2019.
External links [ edit ]
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=NxStage&oldid=1226702354 " C a t e g o r i e s : ● A m e r i c a n c o m p a n i e s e s t a b l i s h e d i n 1 9 9 8 ● H e a l t h c a r e c o m p a n i e s e s t a b l i s h e d i n 1 9 9 8 ● H e a l t h c a r e c o m p a n i e s b a s e d i n M a s s a c h u s e t t s ● 1 9 9 8 e s t a b l i s h m e n t s i n M a s s a c h u s e t t s ● 2 0 0 5 i n i t i a l p u b l i c o f f e r i n g s ● 2 0 1 9 m e r g e r s a n d a c q u i s i t i o n s ● C o m p a n i e s b a s e d i n L a w r e n c e , M a s s a c h u s e t t s ● C o m p a n i e s f o r m e r l y l i s t e d o n t h e N a s d a q ● M e d i c a l d e v i c e m a n u f a c t u r e r s ● M e d i c a l t e c h n o l o g y c o m p a n i e s o f t h e U n i t e d S t a t e s ● A m e r i c a n s u b s i d i a r i e s o f f o r e i g n c o m p a n i e s H i d d e n c a t e g o r i e s : ● C S 1 e r r o r s : e x t e r n a l l i n k s ● O f f i c i a l w e b s i t e n o t i n W i k i d a t a
● T h i s p a g e w a s l a s t e d i t e d o n 1 J u n e 2 0 2 4 , a t 0 9 : 0 2 ( U T C ) . ● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n . ● P r i v a c y p o l i c y ● A b o u t W i k i p e d i a ● D i s c l a i m e r s ● C o n t a c t W i k i p e d i a ● C o d e o f C o n d u c t ● D e v e l o p e r s ● S t a t i s t i c s ● C o o k i e s t a t e m e n t ● M o b i l e v i e w
$393 million (2017)
